J-VAC® vaccine is a broad-spectrum bacterin-toxoid that protects against coliform mastitis caused by Escherichia coli and the effects of endotoxemia caused by E. coli and Salmonella Typhimurium.
It is approved for a whole-herd protocol and can be used for lactating cows, heifers or dry cows.
Features & Benefits
Whole-Herd Protection
J-VAC® vaccine is the only vaccine of its kind approved for usage in the whole herd. In just two doses, J-VAC vaccine protects against coliform mastitis caused by E. coli and endotoxemia caused by E. coli and Salmonella Typhimurium. The unique TANDEM™ adjuvant in J-VAC vaccine keeps antigens in suspension, releases them over time, and stimulates enhanced immunity.
Flexible Administration
- J-VAC vaccine is easy to administer with a whole herd, two-dose protocol, and can reduce the incidence of clinical coliform mastitis cases by 81%.*
- Labeled for flexible administration, with intramuscular and subcutaneous injection-route options.
*Data on file at Boehringer Ingelheim
Dosage & Administration
Administration
- For vaccination against coliform mastitis, inject one 2 mL dose intramuscularly or subcutaneously at seven months of gestation or at dry-off. Revaccinate one to three weeks before calving. Approved for whole-herd use.
Timing
- For vaccination against the effects of endotoxemia, whole-herd vaccination may be done at any time. Vaccinate with one 2 mL dose followed by a second 2 mL dose two to four weeks later.
